RWE upstart maps a new global plan as investors pour in the latest mega-round
As regulators continue to rely more on real world evidence, New York-based RWE leader Aetion said Tuesday that it has closed a $110 million Series C funding round, led by Warburg Pincus.
The company said it will use the new funds to extend the capabilities of its RWE platform, used by many top biopharma companies, expand its European and Asian-Pacific footprint, and grow its commercial team to serve new clients. Aetion has now raised a total of $212 million to date.
Unlock this article instantly by becoming a free subscriber.
You’ll get access to free articles each month, plus you can customize what newsletters get delivered to your inbox each week, including breaking news.